ANTIDEPRESSANT MEDICATIONS
New research links acohol consumption to increased mood instability in bipolar disorder
The researchers, including those from the University of Michigan, US, wanted to understand the long-term effects of consuming alcohol on the mood and functioning of adults having bipolar disorder. The findings are published in The Journal of the American Medical Association (JAMA) Network Open.
A realistic way to protect kids from social media? Find a middle ground
Ahmed Othman, a teenager from Massachusetts, avoids TikTok and credits his parents, computer scientists, for teaching him about social media's impact on mental health. He is among the minority of teens not on TikTok, as per Pew Research Center data.
Quest Labs stock debuts with 60% premium on NSE SME platform
Quest Laboratories made its debut on the NSE SME platform on Thursday, starting with a 60% premium. The stock opened at Rs 155, surpassing its issue price of Rs 97. Before its listing, the company's shares were trading at a premium of Rs 80 in the unlisted market.
Quest Laboratories IPO opens today: Check issue size, price band, GMP and other details
Quest Laboratories SME IPO opens today to raise Rs 43 crore through a fresh equity issue of 44.49 lakh shares at Rs 93-97 apiece on NSE SME platform. India's pharmaceutical industry, known for generic drugs and vaccines, ranks third globally with a 9.43% CAGR over nine years.
What’s the best way to treat irritable bowel syndrome?
A new study suggests that certain dietary changes may be more effective than medication
Strides Pharma gets USFDA nod for antidepressant medication
As per IMS, Fluoxetine tablets have a market size of USD 23.9 million. This approval further strengthens the company's presence in the Fluoxetine portfolio, complementing the existing approval of Fluoxetine capsules, which has a market size of USD106 million, the Bengaluru based firm said.
- Go To Page 1
Is ketamine poisonous? Debunking 6 myths around the drug that claimed Matthew Perry’s life
The drug, which is primarily used as a pain-relieving anaesthetic during surgeries, was also utilised by doctors to treat PTSD and severe depression.
Health anxiety can be fatal: Swedish study finds people with hypochondria have shorter lifespans
Hypochondriasis, now called illness anxiety disorder, is a rare condition with symptoms that go beyond average health worries.
Hyderabad's pictureque Durgam Cheruvu lake water has antidepressants, painkillers, sewage and even cocaine
Researchers have found a cocktail of pollutants in Hyderabad's Durgam Cheruvu lake. In addition to pollutants such as cyanotoxins, pesticides and UV filters, researchers identified 183 compounds of organic micropollutants such as antidepressants, painkillers, anti-obesity medications, and even traces of cocaine. Experts called for immediate action to treat contaminated water, with strict waste management and regulation.
FDA approves first postpartum depression pill
The FDA has approved a pill, Zurzuvae, to treat severe depression after childbirth, a condition that affects thousands of new mothers in the US each year. Postpartum depression affects an estimated 400,000 people a year, and while it often ends on its own within a couple of weeks, it can continue for months or even years. The standard treatment includes counselling or antidepressants, which can take weeks to work and don't help everyone.
Alembic Pharma gets USFDA nod to market generic antidepressant drug
The company's product is therapeutically equivalent to Otsuka Pharmaceutical Co's reference listed drug product Rexulti tablets, it added. Brexpiprazole tablets are indicated as an adjunctive therapy to antidepressants for the treatment of major depressive disorder and for the treatment of schizophrenia.
Sun Pharma recalls over 10,000 bottles of generic anti-depression drug in US
As per the USFDA, Sun Pharma is recalling the affected lot due to "presence of foreign substance: Customer complaint for the presence of dark, gritty substance found within the bottle, which was determined to be activated carbon from the desiccant canister inside the bottle".
Drug shortages persist in Russia after start of Ukraine war
Experts and health authorities in Russia say the drug shortages are temporary - due to panic- buying and logistical difficulties for suppliers from the sanctions - but some remain worried that high-quality medicines will keep disappearing in the Russian market.
Sun Pharma enters licensing pact with Lundbeck to launch novel anti-depressant pill in India
Vortioxetine is a novel antidepressant with multimodal activity, which is approved to treat Major Depressive Disorder (MDD) in adults.
Granules India gets USFDA nod for generic antidepressant drug
"We are pleased to receive approval of Bupropion Hydrochloride (XL) tablet product within first review cycle of 10 months from filing date. This product will be a valuable addition to our growing modified release product portfolio in the US market," GPI Executive Director Priyanka Chigurupati stated.
Antidepressant fluvoxamine may reduce risk of COVID-19 hospitalisation: Lancet study
Fluvoxamine is currently used to treat mental health conditions such as depression and obsessive-compulsive disorders. It was chosen for study as a potential treatment for COVID-19 due to its anti-inflammatory properties.
Zydus Cadila gets USFDA nod for antidepressant drug
Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Nortriptyline Hydrochloride capsules USP, in strengths of 10 mg, 25 mg, 50 mg and 75 mg, Cadila Healthcare said in a regulatory filing.
Pandemic triggers big swings in prescription drug use
Express Scripts, a top prescription benefit manager with over 100 million customers, saw big jumps in people getting three-month refills via mail delivery, as people with chronic health problems stocked up early in the crisis. Refills jumped 18 per cent between mid-March and mid-April.
SPV Foundation posts Rs 3 cr grant for bioscience research; TIFR scientist Vidita Vaidya bags research grant
Vidita’s Neurobiology lab at TIFR currently studies the molecular, epigenetic and cellular changes that contribute to persistent alterations in human behaviour. It also focusses on molecular and cellular adaptations that arise from sustained antidepressant treatment.
Better late than never: Why you need to start exercising today, for a minimum of 20 mins
Exercise results in better BP and blood sugar control, favourably affects the lipids, improves bone density and lowers the risk of a host of diseases.
Zydus Pharma recalls 44.8 K bottles of antidepressant in US
The reason for recall is presence of foreign tablets. "Risperidone tablets were found in bottle of paroxetine tablets", the report said.
Now, a party drug and Botox can be used to treat depression
Researchers are trying to work out if removing people's wrinkles with Botox simply makes them feel better or if there is some other effect.
Aurobindo recalls 47,000 bottles of antidepressant capsules in US
The US arm of Aurobindo Pharma is recalling 47,040 bottles of Venlafaxine Hydrochloride extended release capsules, manufactured by the Hyderabad-based firm, from the American market.
Motion-tracking wristband may help tackle depression
McCall suggests that a smart wristband may help by identifying those commonly referred to as "night owls," who appear to be the best responders to SSRIs.
Sun Pharma recalls 68,194 bottles of anti-depression drug in US
The 37.5 mg tablets in 30-count bottles and 90-count bottles, were manufactured by Sun Pharmaceutical Industries at Halol for Sun Pharma Global Inc, Dubai.
Single dose of antidepressant changes brain
A single dose of antidepressant is enough to produce dramatic changes in the functional architecture of the human brain, scientists have found.
Antidepressants may change how you feel about your partner
Taking antidepressants may affect people's feelings of love and attachment towards their partner, a new study has found.
Sun Pharma subsidiary recalls some lots of antidepressant drug Venlafaxine Hydrochloride from US market
Venlafaxine Hydrochloride extended-release tablets are indicated for the treatment of major depressive disorder.
Sun Pharma recalls over 4 lakh bottles of two drugs in US
Drug major Sun Pharmaceuticals is recalling over 4 lakh bottles of anti-depressant and anti-allergy drugs in the US for failing to meet specifications.
Load More
